Sector: Pharmaceuticals

Latest content

WTR Brand Elite analysis: December 2021

Featured in Stock market performance

The WTR Brand Elite indices rose five points in the month ending 31 December, hitting its highest level since we started tracking the indices four years ago.

20 January 2022

New bill aimed at tackling illegal online pharmacies introduced in US Senate

One market expert tells WTR that, if enacted, the bipartisan bill would provide powerful new protections to keep consumers safe from counterfeit and illegal drugs.

16 December 2021

Are VITAYUMMY and YUMMI GUMMI confusingly similar?

This dispute between rival companies in the gummy vitamins sector shows the additional flexibility provided by an assessment under the Danish Marketing Practices Act.

13 December 2021

Board of Appeal confirms ex officio ISIPO refusal of pharma mark

The refusal of pharmaceutical company Alvogen’s appeal highlights the importance of the principle of interdependence in the assessment of the likelihood of conclusion.

06 December 2021

Pfizer’s opposition against registration of RUXXIMLA partially successful

The case confirms that the high degree of attention of the relevant public in respect of goods/services related to the medical field does not automatically rule out the existence of a likelihood of confusion.

26 November 2021

Johnson & Johnson decides bigger is not better

The corporate schism will enable the company to spend more time nurturing and promoting its household brands.

19 November 2021

Inside the battle against illegal online pharmacies: interview with ASOP Global

WTR sits down with Libby Baney from the Alliance for Safe Online Pharmacies to get the inside track on their efforts to combat illegal online drug sales.

28 October 2021

A danger to millions: why counterfeiting should be included among crimes against humanity

With a petition set for the International Criminal Court, it is about time the dangers of counterfeit goods are considered among the list of crimes against humanity, argues our Saturday opinion.

23 October 2021

Covid and counterfeits: how brand owners are fighting back against pandemic opportunists

In an exclusive guest post, experts at Gowling look at how brand owners have tackled a significant rise in counterfeit goods during the covid-19 pandemic.

21 October 2021

HELIOS v HEALIOS: General Court considers likelihood of confusion in the medical field

This decision of the General Court highlights that, when it comes to goods and services with a medical purpose, it might not be sufficient to argue that their ultimate purpose can overlap with their medical application in order to establish similarity.

20 October 2021

Unlock unlimited access to all WTR content